收稿日期: 2022-03-02
网络出版日期: 2025-04-12
基金资助
国家重点研发计划(2018YFE0104200);国家自然科学基金(82172065)
版权
Biocompatibility of 3D printed biodegradable WE43 magnesium alloy scaffolds and treatment of bone defects
Received date: 2022-03-02
Online published: 2025-04-12
Supported by
the National Key Research and Development Program of China(2018YFE0104200);National Natural Science Foundation of China(82172065)
Copyright
目的: 探讨3D打印工艺制造的多孔WE43镁合金支架的生物相容性, 并观察其治疗新西兰大白兔股骨缺损的效果。方法: 利用Sprague Dawley(S-D)大鼠骨髓间充质干细胞进行体外细胞毒性试验, 根据培养液不同将细胞分为100%浸提液组、50%浸提液组、10%浸提液组及对照组, 将各组细胞分别培养1、3及7 d后, 采用细胞计数试剂盒8(cell counting kit-8, CCK-8)法测定各组细胞活性。体内实验中, 随机将3.0~3.5 kg新西兰大白兔分成实验组、骨水泥组与空白组3组, 每组9只, 每只均对左侧股骨外侧髁进行手术, 利用骨钻制造直径5 mm、深6 mm的骨缺损, 其中实验组植入WE43镁合金支架, 骨水泥组植入硫酸钙骨水泥, 空白组不做植入。在术后4、8与12周分别对每组3只进行二氧化碳麻醉法安乐死, 对股骨及重要内脏器官进行取材, 对左股骨外侧髁进行微计算机断层扫描(micro-computed tomography, Micro-CT)。对重要内脏器官制备切片, 并使用苏木精-伊红(hematoxylin-eosin, HE)染色, 对股骨外侧髁制作硬组织切磨片, 使用亚甲基蓝酸性品红染色, 在显微镜下观察。结果: 细胞毒性试验中, 培养1 d时, 100%浸提液组细胞存活率高于对照组(140.56% vs. 100.00%, P<0.05); 培养3 d时, 各组细胞存活率差异无统计学意义(P>0.05);培养7 d时, 100%浸提液组细胞存活率低于对照组(68.64% vs. 100.00%, P<0.05)。体内实验中Micro-CT扫描发现实验组在4周时大部分支架均已降解, 高密度的支架所剩很少, 12周时已无明显支架轮廓。在4周时, WE43镁合金支架周围有一定量气体生成, 在8~12周时, 气体明显减少。硬组织切磨片显示, 实验组4周时支架周围有一定量细胞外基质和类骨质生成, 骨水泥组中硫酸钙骨水泥已大部分降解, 8周时实验组支架及其降解产物周围的类骨质明显增多, 12周时实验组支架周围有新生骨与支架接触, 骨水泥组与空白组新生骨较少。结论: 3D打印工艺制造的多孔WE43镁合金支架生物相容性良好, 具有良好的成骨性能, 有潜力成为修补骨缺损的新型材料。
闵树元 , 田耘 . 3D打印生物可降解WE43镁合金支架的生物相容性及对骨缺损的治疗[J]. 北京大学学报(医学版), 2025 , 57(2) : 309 -316 . DOI: 10.19723/j.issn.1671-167X.2025.02.014
Objective: To investigate the biocompatibility of porous WE43 magnesium alloy scaffolds manufactured by 3D printing technology and to observe its effect in treating femoral defects in New Zealand white rabbits. Methods: In vitro cytotoxicity test was performed using bone marrow mesenchymal stem cells from Sprague Dawley (S-D) rats. According to the different culture media, the cells were divided into 100% extract group, 50% extract group, 10% extract group and control group. After culturing for 1, 3 and 7 days, the cell activity of each group was determined by cell counting kit-8 (CCK-8). In the in vivo experiment, 3.0-3.5 kg New Zealand white rabbits were randomly divided into three groups: Experimental group, bone cement group and blank group, with 9 rabbits in each group. Each rabbit underwent surgery on the left lateral femoral condyle, and a bone defect with a diameter of 5 mm and a depth of 6 mm was created using a bone drill. The experimental group was implanted with WE43 magnesium alloy scaffolds, the bone cement group was implanted with calcium sulfate bone cement, and the blank group was not implanted. Then 4, 8 and 12 weeks after surgery, 3 rabbits in each group were euthanized by carbon dioxide anesthesia, and the femur and important internal organs were sampled. Micro-computed tomography (Micro-CT) scanning was performed on the left lateral femoral condyle. Sections of important internal organs were prepared and stained with hematoxylin-eosin (HE). Hard tissue sections were made from the left lateral femoral condyle and stained with methylene blue acid fuchsin and observed under a microscope. Results: In the cytotoxicity test, the cell survival rate in the 100% extract group was higher than that in the control group (140.56% vs. 100.00%, P < 0.05) on 1 day of culture; there was no statistically significant difference (P>0.05) in cell survival rate among the groups on 3 days of culture; the cell survival rate in the 100% extract group was lower than that in the control group (68.64% vs. 100.00%, P < 0.05) on 7 days of culture. Micro-CT scanning in the in vivo experiment found that most of the scaffolds in the experimental group had been degraded in 4 weeks, with very few high-density scaffolds remaining. In 12 weeks, there was no obvious stent outline. In 4 weeks, a certain amount of gas was generated around the WE43 magnesium alloy scaffold, and the gas was significantly reduced from 8 to 12 weeks. Hard tissue sections showed that a certain amount of extracellular matrix and osteoid were generated around the scaffolds in the experimental group in 4 weeks. In the bone cement group, most of the calcium sulfate bone cement had been degraded. In 8 weeks, the osteoid around the scaffold and its degradation products in the experimental group increased significantly. In 12 weeks, new bone was in contact with the scaffold around the scaffold in the experimental group. There was less new bone in the bone cement group and the blank group. Conclusion: The porous WE43 magnesium alloy scaffold fabricated by 3D printing process has good biocompatibility and good osteogenic properties, and has the potential to become a new material for repairing bone defects.
Key words: Biodegradable implants; Bone graft; Magnesium alloy; 3D printing; Bone defect
| 1 | Archunan MW , Petronis S . Bone grafts in trauma and orthopaedics[J]. Cureus, 2021, 13 (9): e17705. |
| 2 | Grambart ST , Anderson DS , Anderson TD . Bone grafting options[J]. Clin Podiatr Med Surg, 2020, 37 (3): 593- 600. |
| 3 | Lodoso-Torrecilla I , van den Beucken J , Jansen JA . Calcium phosphate cements: Optimization toward biodegradability[J]. Acta Biomater, 2021, 119, 1- 12. |
| 4 | Kani KK , Porrino JA , Chew FS . External fixators: Looking beyond the hardware maze[J]. Skeletal Radiol, 2020, 49 (3): 359- 374. |
| 5 | Deng F , Liu L , Li Z , et al. 3D printed Ti6Al4V bone scaffolds with different pore structure effects on bone ingrowth[J]. J Biol Eng, 2021, 15 (1): 4. |
| 6 | Sumner DR . Long-term implant fixation and stress-shielding in total hip replacement[J]. J Biomech, 2015, 48 (5): 797- 800. |
| 7 | Karunakaran R , Ortgies S , Tamayol A , et al. Additive manufacturing of magnesium alloys[J]. Bioact Mater, 2020, 5 (1): 44- 54. |
| 8 | Zhang J , Jiang Y , Shang Z , et al. Biodegradable metals for bone defect repair: A systematic review and meta-analysis based on animal studies[J]. Bioact Mater, 2021, 6 (11): 4027- 4052. |
| 9 | Witte F , Hort N , Vogt C , et al. Degradable biomaterials based on magnesium corrosion[J]. Curr Opin Solid State Mater Sci, 2008, 12 (5/6): 63- 72. |
| 10 | Saris NE , Mervaala E , Karppanen H , et al. Magnesium. An update on physiological, clinical and analytical aspects[J]. Clin Chim Acta, 2000, 294 (1/2): 1- 26. |
| 11 | Janning C , Willbold E , Vogt C , et al. Magnesium hydroxide temporarily enhancing osteoblast activity and decreasing the osteoclast number in peri-implant bone remodelling[J]. Acta Biomater, 2010, 6 (5): 1861- 1868. |
| 12 | Zhang X , Chen Q , Mao X . Magnesium enhances osteogenesis of BMSCs by tuning osteoimmunomodulation[J]. Biomed Res Int, 2019, 2019, 7908205. |
| 13 | Leem YH , Lee KS , Kim JH , et al. Magnesium ions facilitate integrin alpha 2- and alpha 3-mediated proliferation and enhance alkaline phosphatase expression and activity in hBMSCs[J]. J Tissue Eng Regen Med, 2016, 10 (10): E527- E536. |
| 14 | Chen K , Xie X , Tang H , et al. In vitro and in vivo degradation behavior of Mg-2Sr-Ca and Mg-2Sr-Zn alloys[J]. Bioact Mater, 2020, 5 (2): 275- 285. |
| 15 | Xia D , Liu Y , Wang S , et al. In vitro and in vivo investigation on biodegradable Mg-Li-Ca alloys for bone implant application[J]. Sci China Mater, 2018, 62 (2): 256- 272. |
| 16 | Li Z , Gu X , Lou S , et al. The development of binary Mg-Ca alloys for use as biodegradable materials within bone[J]. Biomaterials, 2008, 29 (10): 1329- 1344. |
| 17 | He LY , Zhang XM , Liu B , et al. Effect of magnesium ion on human osteoblast activity[J]. Braz J Med Biol Res, 2016, 49 (7): e5257. |
| 18 | International Organization for Standardization. Biological evaluation of medical devices. Part 12: Sample preparation and reference materials: ISO 10993-12: 2021[S]. Switzerland: Vernier, 2021: 01. |
| 19 | Morgan EF , Unnikrisnan GU , Hussein AI . Bone mechanical pro-perties in healthy and diseased states[J]. Annu Rev Biomed Eng, 2018, 20, 119- 143. |
| 20 | Cuppone M , Seedhom BB , Berry E , et al. The longitudinal Young's modulus of cortical bone in the midshaft of human femur and its correlation with CT scanning data[J]. Calcif Tissue Int, 2004, 74 (3): 302- 309. |
| 21 | Lu WC , Pringa E , Chou L . Effect of magnesium on the osteogenesis of normal human osteoblasts[J]. Magnes Res, 2017, 30 (2): 42- 52. |
| 22 | Zheng YF , Gu XN , Witte F . Biodegradable metals[J]. Mater Sci Eng R Rep, 2014, 77, 1- 34. |
| 23 | Gu XN , Xie XH , Li N , et al. In vitro and in vivo studies on a Mg-Sr binary alloy system developed as a new kind of biodegradable metal[J]. Acta Biomater, 2012, 8 (6): 2360- 2374. |
| 24 | von der H?h N , von Rechenberg B , Bormann D , et al. Influence of different surface machining treatments of resorbable magnesium alloy implants on degradation-EDX-analysis and histology results[J]. Materwiss Werksttech, 2009, 40 (1/2): 88- 93. |
| 25 | Witte F , Fischer J , Nellesen J , et al. In vitro and in vivo corrosion measurements of magnesium alloys[J]. Biomaterials, 2006, 27 (7): 1013- 1018. |
| 26 | Feyerabend F , Fischer J , Holtz J , et al. Evaluation of short-term effects of rare earth and other elements used in magnesium alloys on primary cells and cell lines[J]. Acta Biomater, 2010, 6 (5): 1834- 1842. |
| 27 | Li F , Gong A , Qiu L , et al. Simultaneous determination of trace rare-earth elements in simulated water samples using ICP-OES with TODGA extraction/back-extraction[J]. PLoS One, 2017, 12 (9): e0185302. |
| 28 | Angrisani N , Reifenrath J , Zimmermann F , et al. Biocompatibility and degradation of LAE442-based magnesium alloys after implantation of up to 3.5 years in a rabbit model[J]. Acta Biomater, 2016, 44, 355- 365. |
/
| 〈 |
|
〉 |